Five Narrow Lane LP discloses 0.29% INVO Fertility (IVF) stake

Rhea-AI Filing Summary

INVO Fertility, Inc. received an amended ownership report from Five Narrow Lane LP, which now reports beneficial ownership of 6,935 shares of common stock. This represents 0.29% of INVO Fertility’s outstanding common stock, based on 2,386,826 shares outstanding as of December 16, 2025 as cited from a prior prospectus. Five Narrow Lane LP reports sole voting and dispositive power over all 6,935 shares and no shared power.

The filing notes that the position represents ownership of 5 percent or less of the class. Five Narrow Lane LP also certifies that the securities were not acquired and are not held for the purpose of changing or influencing control of INVO Fertility, but instead reflect a passive investment. The amendment is signed by Arie Rabinowitz as Managing Member of the general partner.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

INVO FERTILITY, INC.

(Name of Issuer)

COMMON STOCK, $0.001 PAR VALUE PER SHARE

(Title of Class of Securities)

44984F807

(CUSIP Number)

01/20/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 44984F807

1

Names of Reporting Persons

Five Narrow Lane LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 6,935.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 6,935.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,935.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.29 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Note to 5, 7 and 11: Based on 2,386,826 shares outstanding as of December 16, 2025 pursuant to a Form 424B4 filed on December 31, 2025 with the Securities and Exchange Commission.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: INVO FERTILITY, INC.
(b)	Address of issuer's principal executive offices: 5582 Broadcast Court, Sarasota, FL 34240
Item 2.
(a)	Name of person filing: Five Narrow Lane LP
(b)	Address or principal business office or, if none, residence: 510 Madison Avenue, Suite 1400, New York, NY 10022
(c)	Citizenship: New York
(d)	Title of class of securities: COMMON STOCK, $0.001 PAR VALUE PER SHARE
(e)	CUSIP No.: 44984F807
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 6,935.00
(b)	Percent of class: 0.29%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 6,935.00
	(ii) Shared power to vote or to direct the vote: 0 Shares
	(iii) Sole power to dispose or to direct the disposition of: 6,935.00
	(iv) Shared power to dispose or to direct the disposition of: 0 Shares
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Five Narrow Lane LP

Signature:	/s/ Arie Rabinowitz
Name/Title:	Arie Rabinowitz/Managing Member of the General Partner
Date:	01/21/2026

FAQ

What does Five Narrow Lane LP report in this Schedule 13G/A for IVF?

Five Narrow Lane LP reports beneficial ownership of 6,935 shares of INVO Fertility, Inc. common stock, representing 0.29% of the outstanding shares.

How much of INVO Fertility, Inc. does Five Narrow Lane LP own?

Five Narrow Lane LP reports ownership of 0.29% of INVO Fertility, Inc.’s common stock, based on 2,386,826 shares outstanding as of December 16, 2025.

Does Five Narrow Lane LP have control over the IVF shares it reports?

Yes. Five Narrow Lane LP reports sole voting power and sole dispositive power over all 6,935 shares, with no shared voting or dispositive power.

Is Five Narrow Lane LP reporting ownership of more than 5% of INVO Fertility (IVF)?

No. The filing states that Five Narrow Lane LP has ownership of 5 percent or less of INVO Fertility, Inc.’s common stock.

What does the certification in the IVF Schedule 13G/A say about control intent?

The certifying party states that the securities were not acquired and are not held for the purpose or effect of changing or influencing the control of INVO Fertility, Inc., and are not held in connection with any such transaction, except for activities solely related to a nomination under Rule 240.14a-11.

Who signed the Schedule 13G/A filed for INVO Fertility, Inc.?

The Schedule 13G/A was signed by /s/ Arie Rabinowitz, identified as Managing Member of the General Partner, dated 01/21/2026.